John Whelan: Pharmaceutical sector learning to live with uncertainty
Johnson & Johnson was one of a number of pharmaceutical companies with operations in Ireland to announce US investment in response to tariff threats from Donald Trump.
The sedate world of pharmaceutical trading was abruptly shattered as soon as US president Donald Trump took the oath of office last January and issued a barrage of executive orders.
It became clear he intended weaponising his economic policy with a scattergun of tariffs on imports from friends and foes alike.
